Delisting, Listing Rule Failure, or Listing Transfer

SEC Filing Summary

Registrant: Coeptis Therapeutics Holdings, Inc. The request metadata identifies “Z Squared Inc.,” but the filing names Coeptis Therapeutics Holdings, Inc. as the registrant.

Business Context and Reporting Period

This Form 8-K was filed June 9, 2023, under Items 3.01 and 8.01. It reports Nasdaq’s approval to transfer the company’s common stock and warrants from The Nasdaq Global Market to The Nasdaq Capital Market.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It is principally a securities-listing and compliance disclosure.

Material Changes

  • The transfer to the Nasdaq Capital Market was scheduled to become effective at the opening of business on June 13, 2023.
  • Nasdaq confirmed that the previously announced deficiency from December 29, 2022 would be deemed closed simultaneously with the transfer.
  • The company’s common stock, trading under COEP, and warrants, trading under COEPW, were identified as Nasdaq-listed securities.

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance or operating outlook. The principal disclosed risk-related matter was the prior Nasdaq listing deficiency; the filing states that Nasdaq approved the transfer and closure of that deficiency. No contingencies, financing arrangements, or unusual financial items are described.

Important Facts to Verify

  • Confirm that the listing transfer occurred on June 13, 2023, as scheduled.
  • Review the December 29, 2022 Form 8-K to understand the deficiency that Nasdaq deemed closed.
  • Verify the trading status and applicable listing requirements for COEP and COEPW on the Nasdaq Capital Market.
  • Review Exhibit 99.1, the June 9, 2023 press release, for any additional management commentary.
  • Reconcile the filing registrant, Coeptis Therapeutics Holdings, Inc., with the request metadata identifying Z Squared Inc.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.